Stevanato Group

Amgen Inc. is an American multinational biopharmaceutical company that discovers, develops, manufactures, and delivers innovative biologic medicines to treat serious illnesses, including cancer, cardiovascular disease, osteoporosis, inflammatory and rare diseases.

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.